News

News
Experimental Cancer Drug May Slow Atherosclerosis Linked to Heart Disease
An experimental cancer, lung disease and Alzheimer's drug may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

News
Potential “Game Changer” Discovery for Prostate Cancer Therapy
Researchers have identified a previously unknown weak spot in prostate cancer cells that could also lead to entirely new therapeutic approaches for other types of cancer.

News
Discovery Finds Molecules Within Us That May Drive Cancerous Mutations
New research has identified that circular RNAs – a recently discovered family of gene fragments – can stick to cellular DNA and cause mutations that result in cancer.

News
Blood Pressure Drugs May Boost Cancer Immunotherapy, Mouse Study Suggests
The study's findings may be applied in the future to significantly improve the effectiveness and applicability of cancer immunotherapy.

News
Role of UV Radiation Revealed in Development of Rare Leukemia in the Skin
The paper is one of the first to uncover the "genetic travelogue" of a cancer that evolves across multiple different tissues.

News
Functional Limitations Are Increasing in Cancer Survivors, Study Finds
In a study of 51,258 survivors weighted to represent a larger population of approximately 178.8 million people, 3.6 million survivors reported a functional limitation in 1999, and that number increased to 8.2 million in 2018.

News
Unexpected Link Found Between Chromosomal Instability and Epigenetic Alterations
New research has uncovered an unexpected link between two hallmarks of cancer: chromosomal instability and epigenetic alterations.

News
Changing Identities May Allow Aggressive Cancer Cells To Grow
Not all cancer metastases have the same destructive effect. Researchers demonstrate different mechanisms in experiments.

News
Novel Resin Enables Generation and Purification of Radium and Actinium for Cancer Therapeutics
Zirconium-based materials have been shown to effectively separate radium and actinium, which could enable the large-scale production of radioisotopes for cancer therapy.

News
Lung Cancer Drug Cuts Risk of Death by 51% in Clinical Trial
Results of a large Phase 3 clinical trial reveal that a targeted cancer drug, osimertinib, cut the risk of death by 51% for patients following surgery to remove non-small cell lung cancers harboring a specific mutation.
Advertisement